Program
The previous International Symposium was focussed on regulatory autoantibodies:
- Contribution of RABs to the pathogenesis of diseases and disease manifestations
- Diagnostic methodologies and their associated challenges.
- The potential of anti-GPCR antibodies as biomarkers for diseases and therapeutic interventions.
What is our Symposium about
- We promote interdisciplinary conversations and strengthen research network.
- We identify new pathogenic targets, biomarkers, and intricate signallingpathways to provide a comprehensive perspective on disease pathogenesis.
- We propose and pioneer new therapeutic strategies.
9:00 a.m. | Desk opening |
10:00 a.m. | Welcome address: Thomas Münte, Universität zu Lübeck |
10:15 a.m. | Current concepts in the development of autoimmune diseases Yehuda Shoenfeld 5th anniversary RAB: Challenges in GPCR ab research: from biomarker research to precision medicine Gabriela Riemekasten |
11:25 a.m. | Coffee break |
11:55 a.m. | Session: Regulation of Chronic Inflammation: Chair: Guido Moll Identification of novel functional autoantibodies associated with systemic sclerosis Xinhua Yu & Jacqueline Wax Anti-GPCR ab correlations: lessons from systemic sclerosis and its vascular and fibrotic complications Susanne Schinke Age-associated dynamics of the autoantibodyome: a way to stay old and healthy Otavio Cabral Marques |
12:55 p.m. | Lunch and Posterwalk |
14:05 p.m. | Session: RABS in Neuroimmunology: Chair: Gabriela Riemekasten New insights of RABs in myalgic encephalomyelitis / chronic fatigue syndrom ME/CFS and post Covid syndrome. Carmen Scheibenbogen EBV-reacitve antibodies crossreact with GPCR and other autoantigens in ME/CFS: from immunoadsorption to B cell depletion Franziska Sotzny Autoimmune Neuroinflammation – Pathogenic and Regulatory Autoantibodies Friedemann Paul Phenotypes of autonomic dysfunction in post-COVID syndrome can be related to signatures of regulatory autoantibodies Frank C. Mooren Emerging potential of CAR-T Cell therapy in Neurology Aiden Haghikia |
15:45 p.m. | Coffee Break and Poster Session |
16:15 p.m. |
Session: Inside Antibody Induced Cellular Functions |
17:25 p.m. | Closing |
9:00 a.m. | Desk opening |
10:00 a.m. | Session: RABs as Precision Biomarker in Immunity, Cancer and Transplantation Chair: Torsten Witte Autoantibodies in transplantation Guido Moll Regulatory autoantibodies targeting GPCRs in transplant rejection and glomerulonephritis Miroslav Banasik Endothelin-1 directed RABs in systemic sclerosis Pinchao Wang Vasculitis pathogenesis driven by regulatory antibodies: insights from AAV, GCA, and EGPA Sebastian Klapa |
11:40 a.m. | Coffee break |
12:10 a.m. | Session: Insight Beyond anti-GPCR as Biomarker: Chair: Carmen Scheibenbogen PAR2 abs and other GPCR abs as predictors in Ischemic Stroke Matthias Endres Antibodies against muscarinic receptors in Sjögren‘s syndrome Torsten Witte Calcium-sensing-receptor (CASR)-specific autoantibodies Michael Adu-Gyamfi Gut dysmotility through GPCR abs in Systemic Sclerosis Konstantinos Fourlakis |
13:30p.m. | Lunch and Poster Session |
14:30 p.m. | Session: Complexity of RABs and Vesicles Chair: Franziska Sotzny RABs and exosomes in rheumatoid arthritis: from tissue priming to tissue damage Markus Hoffmann Axis of trouble: AT1R, AT1R-abs and AT1R-EVs in scleroderma-associated interstitial lung disease Alexander Hackel Revised insights into exosome characteristics in systemic sclerosis Maike Winziers |
15:25 p.m. | Coffee Break |
15:55 p.m. | Session: Therapeutic Targeting Chair: Yehuda Shoenfeld Autoantibody targeting in post Covid and ME/CFS: from immunoadsorption to B cell depletion. Carmen Scheibenbogen RABs in chronic inflammation and as predictors of therapy in psoriatic arthritis and inflammatory bowel disease Hanna Graßhoff |
16:45 p.m. | Closing Remarks Gabriela Riemekasten |